Search Results - "De Feo, A."

Refine Results
  1. 1

    CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling by Ventura, S, Aryee, D N T, Felicetti, F, De Feo, A, Mancarella, C, Manara, M C, Picci, P, Colombo, M P, Kovar, H, Carè, A, Scotlandi, K

    Published in Oncogene (28-07-2016)
    “…Sarcomas are mesenchymal tumors characterized by blocked differentiation process. In Ewing sarcoma (EWS) both CD99 and EWS-FLI1 concur to oncogenesis and…”
    Get full text
    Journal Article
  2. 2

    AP2α controls the dynamic balance between miR-126&126 and miR-221&222 during melanoma progression by Felli, N, Errico, M C, Pedini, F, Petrini, M, Puglisi, R, Bellenghi, M, Boe, A, Felicetti, F, Mattia, G, De Feo, A, Bottero, L, Tripodo, C, Carè, A

    Published in Oncogene (09-06-2016)
    “…Accumulating evidences have shown the association between aberrantly expressed microRNAs (miRs) and cancer, where these small regulatory RNAs appear to dictate…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A new color vep procedure discloses asymptomatic visual impairments in optic neuritis and glaucoma suspects by Accornero, N., Gregori, B., Galié, E., De Feo, A., Agnesi, R.

    Published in Acta neurologica Scandinavica (01-10-2000)
    “…Objective– To evaluate the reliability of visual evoked potentials obtained with a set of multiple chromatic and achromatic patterns (C‐VEPs) in…”
    Get full text
    Journal Article
  5. 5

    National Policies for Risk Management in Italy by Ghirardini, A, Cardone, R, De Feo, A, Leomporra, G, Cannizzaro, G.D, Sgrò, A, Palumbo, F

    Published in Transplantation proceedings (01-07-2010)
    “…Abstract The Ministry of Health in Italy considers risk management (RM) to be one of the specific objectives to be developed by its national policies, as…”
    Get full text
    Journal Article Conference Proceeding
  6. 6
  7. 7

    CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-[kappa]B signaling by Ventura, S, Aryee, D N T, Felicetti, F, De Feo, A, Mancarella, C, Manara, M C, Picci, P, Colombo, M P, Kovar, H, Carè, A, Scotlandi, K

    Published in Oncogene (28-07-2016)
    “…Sarcomas are mesenchymal tumors characterized by blocked differentiation process. In Ewing sarcoma (EWS) both CD99 and EWSFLI1 concur to oncogenesis and…”
    Get full text
    Journal Article
  8. 8

    AP2[alpha] controls the dynamic balance between miR-126&126 and miR-221&222 during melanoma progression by Felli, N, Errico, M C, Pedini, F, Petrini, M, Puglisi, R, Bellenghi, M, Boe, A, Felicetti, F, Mattia, G, De Feo, A, Bottero, L, Tripodo, C, Carè, A

    Published in Oncogene (09-06-2016)
    “…Accumulating evidences have shown the association between aberrantly expressed microRNAs (miRs) and cancer, where these small regulatory RNAs appear to dictate…”
    Get full text
    Journal Article
  9. 9

    Migraine and ocular pain in "glaucoma suspect" by De Marinis, M, Giraldi, J P, de Feo, A, Rinalduzzi, S, De Benedetti, G, Mollicone, A, Accornero, N

    Published in Cephalalgia (01-05-1999)
    “…A relationship between glaucoma and migraine has been hypothesized by some authors, but not confirmed by others. We studied the prevalence and features of…”
    Get more information
    Journal Article
  10. 10

    Why are employers prodding health-care providers to adopt new management systems?: reducing the cost of health care by De Feo, Joseph A

    Published in Clinical leadership & management review (01-03-2004)
    “…Increasingly concerned about the escalating costs of health-care insurance coverage, the quality of health-care delivery, and the escalating costs of…”
    Get more information
    Journal Article
  11. 11

    Color perimetry with personal computer by Accornero, N, Capozza, M, Rinalduzzi, S, De Feo, A, Filligoi, G C, Capitano, L

    “…Color visual field analysis has proven highly sensitive for early visual impairments diagnosis in M. S., yet it has never attained widespread popularity…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Implementing a strategy successfully by De Feo, Joseph A, Janssen, Alexander

    Published in Measuring business excellence (01-12-2001)
    “…This is the third in a series of articles on strategic deployment and identifies the necessary steps to take in deploying the process. Describes ten such steps…”
    Get full text
    Journal Article
  14. 14

    Neuroimmunotoxicology: Humoral Assessment of Neurotoxicity and Autoimmune Mechanisms by Hassan A. N. El-Fawal, Waterman, Stacey J., De Feo, Anthony, Shamy, Magdy Y.

    Published in Environmental health perspectives (01-10-1999)
    “…The interactions between the nervous and immune systems have been recognized in the development of neurodegenerative disease. This can be exploited through…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Uptake and processing of human platelet factor 4 by hepatocytes by Rucinski, B, Stewart, G J, De Feo, P A, Boden, G, Niewiarowski, S

    “…We previously demonstrated rapid clearance of human platelet factor 4 (PF4) from rabbit and rat blood, its accumulation in the liver, and elimination of PF4…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Breakthrough performance: a way out of predicaments by De Feo, Joseph A

    Published in Handbook of business strategy (01-01-2006)
    “…Purpose - Identify breakthroughs that must occur and a step-by-step process that will enable organizations to achieve improved and sustained results.Design…”
    Get full text
    Journal Article
  19. 19
  20. 20